Our CDMO Capabilities
Why Partner's Choose Eirgen
High-Potency & Containment Specialists
Purpose-built high-containment suites engineered for safe, compliant HPAPI and cytotoxic manufacturing.
Our Customer Experience in Numbers
8.82
Overall Customer
Satisfaction Score
*Scored out of 10*
48%
Rated Our Technical
Capabilities as Excellent
65%
Reported That Eirgen
Exceeded Expectations
100%
Expressed High Confidence in our Product Quality & GMP-Compliance
Achieving Excellence, Together.
20
Since 2005, Eirgen Pharma has been a trusted partner in the development and manufacturing of high-potency pharmaceuticals. With 20 years experience, we continue to deliver innovation, quality, and global impact.
120
Eirgen Pharma proudly partners with over 120 pharmaceutical companies across 60 countries. From development to delivery, we support our partners with reliable, high-quality solutions tailored to complex and high-potency products.
1 Billion
With current capacity at 520 million dosage unit annually, Eirgen Pharma is expanding fast. By 2027, our Waterford facility will deliver up to 1 billion units per year - doubling our output to meet growing global demands.
5
We hold 5 key regulatory approvals;
FDA, EMA, HPRA, PMDA, & MRHA
Our facilities meet the highest global standards - ensuring safe, compliant, and consistent delivery of complex high-potency pharmaceuticals worldwide.
